Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Efficient expression of Human papillomavirus 16 E7 oncoprotein fused to C-terminus of Tobacco mosaic virus (TMV) coat protein using molecular chaperones in Escherichia coli.

Folwarczna J, Moravec T, Plchova H, Hoffmeisterova H, Cerovska N.

Protein Expr Purif. 2012 Sep;85(1):152-7. doi: 10.1016/j.pep.2012.07.008. Epub 2012 Jul 28.

PMID:
22850536
2.

Expression of Human papillomavirus 16 E7ggg oncoprotein on N- and C-terminus of Potato virus X coat protein in bacterial and plant cells.

Plchova H, Moravec T, Hoffmeisterova H, Folwarczna J, Cerovska N.

Protein Expr Purif. 2011 Jun;77(2):146-52. doi: 10.1016/j.pep.2011.01.008. Epub 2011 Jan 23.

PMID:
21266198
4.

Extraction, purification and characterization of the plant-produced HPV16 subunit vaccine candidate E7 GGG.

Buyel JF, Bautista JA, Fischer R, Yusibov VM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jan 1;880(1):19-26. doi: 10.1016/j.jchromb.2011.11.010. Epub 2011 Nov 16.

PMID:
22134037
5.

A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.

Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B.

Vaccine. 2012 Feb 1;30(6):1071-82. doi: 10.1016/j.vaccine.2011.12.029. Epub 2011 Dec 15.

PMID:
22178528
6.

[Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].

Tian HW, Ye ZM, Lu ZH, Jao R, Bian T, Zhao L, Ruan L.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2006 Jun;20(2):33-7. Chinese.

PMID:
16816859
7.

[Prokaryotic expression and purification of human papillomavirus type 11 L2E7 fusion protein vaccine and its immunnogenicity].

Zhang H, Zhao L, Ren J, Gao J, Bian T, Fan JT, Ruan L, Chen XQ, Tian HW.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007 Jun;21(2):156-8. Chinese.

PMID:
17653322
9.

Potato virus X coat protein fusion to human papillomavirus 16 E7 oncoprotein enhance antigen stability and accumulation in tobacco chloroplast.

Morgenfeld M, Segretin ME, Wirth S, Lentz E, Zelada A, Mentaberry A, Gissmann L, Bravo-Almonacid F.

Mol Biotechnol. 2009 Nov;43(3):243-9. doi: 10.1007/s12033-009-9195-3. Epub 2009 Jul 5.

PMID:
19579017
10.

A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.

Granadillo M, Vallespi MG, Batte A, Mendoza O, Soria Y, Lugo VM, Torrens I.

Vaccine. 2011 Jan 29;29(5):920-30. doi: 10.1016/j.vaccine.2010.11.083. Epub 2010 Dec 9.

PMID:
21145912
11.

[Prokaryotic expression and identification of human papillomavirus type 16 E7 protein encoding gene].

Shi QF, Wang BN, Li H, Wei XL, Zhang WD, Cao K, Jiang ZH, Li MY.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Mar;37(2):187-90. Chinese.

PMID:
16608071
12.

Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.

Pumpens P, Razanskas R, Pushko P, Renhof R, Gusars I, Skrastina D, Ose V, Borisova G, Sominskaya I, Petrovskis I, Jansons J, Sasnauskas K.

Intervirology. 2002;45(1):24-32.

PMID:
11937768
13.

Expression, purification, and antibody binding activity of human papillomavirus 16 L1 protein fused to maltose binding protein.

Cho HJ, Hahm MS, Kim MK, Han IK, Jung WW, Choi HG, Kim JA, Oh YK.

Protein Pept Lett. 2007;14(5):417-24.

PMID:
17584165
14.

[Expression and purification of GST-HPV16E7 fusion protein].

Zhang J, Wang T, Xi MR, Han M, Chen Y.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 Nov;40(6):1123-6. Chinese.

PMID:
20067134
15.

Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.

Smith ML, Lindbo JA, Dillard-Telm S, Brosio PM, Lasnik AB, McCormick AA, Nguyen LV, Palmer KE.

Virology. 2006 May 10;348(2):475-88. Epub 2006 Feb 8.

16.

The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.

Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S.

Scand J Immunol. 2012 Jan;75(1):27-37. doi: 10.1111/j.1365-3083.2011.02620.x.

17.

[Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].

Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):584-91. Chinese.

18.

TMV recombinants encoding fused foreign transmembrane domains to the CP subunit caused local necrotic response on susceptible tobacco.

Li Q, Li M, Jiang L, Zhang Q, Song R, Xu Z.

Virology. 2006 May 10;348(2):253-9. Epub 2006 Mar 20.

19.

Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes.

Richards KH, Doble R, Wasson CW, Haider M, Blair GE, Wittmann M, Macdonald A.

J Virol. 2014 Apr;88(8):4173-9. doi: 10.1128/JVI.02546-13. Epub 2014 Jan 29.

20.

Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.

Smahel M, Poláková I, Pokorná D, Ludvíková V, Dusková M, Vlasák J.

Int J Oncol. 2008 Jul;33(1):93-101.

PMID:
18575754

Supplemental Content

Support Center